FDA Inspection
Regeneron Pharmaceuticals IncRegeneron Pharmaceuticals Inc – FDA Inspection, Feb 22, 2013
Record Details
This FDA Inspection record concerns Regeneron Pharmaceuticals Inc, with an inspection on February 22, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 22, 2013
- Product Type
- Drugs
View Company Profile
ID · 21714aba-a498-41ee-969d-08080d01f000
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 819877
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 600.80(b)Review of Adverse Experiences - SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Regeneron Pharmaceuticals Inc
12| Date | Classification | Office | Project area |
|---|---|---|---|
| December 10, 2025 | Not classified | New York District Office | |
| May 1, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 19, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 15, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 21, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Regeneron Pharmaceuticals Inc
- FDA Inspection 1292476 - 2025-12-10
- FDA Inspection 1232732 - 2024-05-01
- FDA Inspection 1228712 - 2024-01-19
- FDA Inspection 1156180 - 2021-10-15
- FDA Inspection 1134447 - 2020-12-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.